Receptors, LHRH, antagonists & inhibitors
- Name
- Receptors, LHRH, antagonists & inhibitors
- Accession Number
- DBCAT002787 (DBCAT003827)
- Description
Not Available
- Drugs
Drug Drug Description Relugolix An oral GnRH receptor antagonist for androgen deprivation therapy in the treatment of advanced prostate cancer. - Drugs & Drug Targets
Drug Target Type Relugolix Serum albumin carrier Relugolix Alpha-1-acid glycoprotein 1 carrier Relugolix P-glycoprotein 1 transporter Relugolix ATP-binding cassette sub-family G member 2 transporter Relugolix Cytochrome P450 3A Subfamily enzyme Relugolix Cytochrome P450 2C8 enzyme Relugolix Cytochrome P450 2B6 enzyme Relugolix Gonadotropin-releasing hormone receptor target